pdufa.bio
HomeReadouts › November 2027

November 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for November 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← October 2027December 2027 →
6 readouts
CRNX · Nov 2027 (est.)
Atumelnant: Congenital Adrenal Hyperplasia
ONC · Nov 2027 (est.)
BGB-3111: B-cell Malignancies
VERA · Nov 2027 (est.)
Atacicept: pMN
REGN · Nov 2027 (est.)
Cemdisiran: Age-related Macular Degeneration (AMD)
MYGN · Nov 2027 (est.)
Niraparib: Solid Tumor
Awaiting dataupdated 8mo ago
ARVN · Nov 2027 (est.)
ARV-471: KRAS G12D Mutation
Awaiting data
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).